Lifecore Biomedical, Inc., headquartered in the United States, is a prominent player in the biotechnology industry, specialising in the development and manufacturing of innovative medical devices and biopharmaceuticals. Founded in 1984, the company has achieved significant milestones, including advancements in its core product lines, which focus on hyaluronic acid-based solutions for various medical applications. With a strong presence in the orthopaedic, ophthalmic, and aesthetic markets, Lifecore is recognised for its commitment to quality and precision. The company’s unique offerings, such as its proprietary manufacturing processes, set it apart from competitors, ensuring high standards and efficacy. Lifecore Biomedical continues to solidify its market position through strategic partnerships and a dedication to research and development, making it a trusted name in the biomedical field.
How does Lifecore Biomedical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Lifecore Biomedical, Inc.'s score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Lifecore Biomedical, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Lifecore Biomedical's climate commitments and initiatives remain unclear, and there is no inherited emissions data from a parent or related organization. The company may need to establish clearer sustainability goals and reporting practices to align with industry standards and expectations regarding carbon emissions and climate action.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Lifecore Biomedical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
